148 related articles for article (PubMed ID: 32491252)
21. Novel synthetic molecules targeting the bacterial RNA polymerase assembly.
André E; Bastide L; Michaux-Charachon S; Gouby A; Villain-Guillot P; Latouche J; Bouchet A; Gualtiéri M; Leonetti JP
J Antimicrob Chemother; 2006 Feb; 57(2):245-51. PubMed ID: 16373430
[TBL] [Abstract][Full Text] [Related]
22. Structure-activity relationships of phenyl-furanyl-rhodanines as inhibitors of RNA polymerase with antibacterial activity on biofilms.
Villain-Guillot P; Gualtieri M; Bastide L; Roquet F; Martinez J; Amblard M; Pugniere M; Leonetti JP
J Med Chem; 2007 Aug; 50(17):4195-204. PubMed ID: 17665895
[TBL] [Abstract][Full Text] [Related]
23. Binding mode characterization of novel RNA polymerase inhibitors using a combined biochemical and NMR approach.
Fruth M; Plaza A; Hinsberger S; Sahner JH; Haupenthal J; Bischoff M; Jansen R; Müller R; Hartmann RW
ACS Chem Biol; 2014 Nov; 9(11):2656-63. PubMed ID: 25207839
[TBL] [Abstract][Full Text] [Related]
24. Design and synthesis of 4'-((5-benzylidene-2,4-dioxothiazolidin-3-yl)methyl)biphenyl-2-carbonitrile analogs as bacterial peptide deformylase inhibitors.
Khan FA; Patil RH; Shinde DB; Sangshetti JN
Chem Biol Drug Des; 2016 Dec; 88(6):938-944. PubMed ID: 27401234
[TBL] [Abstract][Full Text] [Related]
25. GroEL/ES inhibitors as potential antibiotics.
Abdeen S; Salim N; Mammadova N; Summers CM; Frankson R; Ambrose AJ; Anderson GG; Schultz PG; Horwich AL; Chapman E; Johnson SM
Bioorg Med Chem Lett; 2016 Jul; 26(13):3127-3134. PubMed ID: 27184767
[TBL] [Abstract][Full Text] [Related]
26. Syntheses of novel myxopyronin B analogs as potential inhibitors of bacterial RNA polymerase.
Lira R; Xiang AX; Doundoulakis T; Biller WT; Agrios KA; Simonsen KB; Webber SE; Sisson W; Aust RM; Shah AM; Showalter RE; Banh VN; Steffy KR; Appleman JR
Bioorg Med Chem Lett; 2007 Dec; 17(24):6797-800. PubMed ID: 17980587
[TBL] [Abstract][Full Text] [Related]
27. Synthesis and structure-activity relationship of novel bisindole amidines active against MDR Gram-positive and Gram-negative bacteria.
Liu Y; Hu X; Wu Y; Zhang W; Chen X; You X; Hu L
Eur J Med Chem; 2018 Apr; 150():771-782. PubMed ID: 29604581
[TBL] [Abstract][Full Text] [Related]
28. Antimicrobial properties and mode of action of the pyrrothine holomycin.
Oliva B; O'Neill A; Wilson JM; O'Hanlon PJ; Chopra I
Antimicrob Agents Chemother; 2001 Feb; 45(2):532-9. PubMed ID: 11158751
[TBL] [Abstract][Full Text] [Related]
29. Development of Methionyl-tRNA Synthetase Inhibitors as Antibiotics for Gram-Positive Bacterial Infections.
Faghih O; Zhang Z; Ranade RM; Gillespie JR; Creason SA; Huang W; Shibata S; Barros-Álvarez X; Verlinde CLMJ; Hol WGJ; Fan E; Buckner FS
Antimicrob Agents Chemother; 2017 Nov; 61(11):. PubMed ID: 28848016
[TBL] [Abstract][Full Text] [Related]
30. Green Synthesis, Biological Activity Evaluation, and Molecular Docking Studies of Aryl Alkylidene 2, 4-thiazolidinedione and Rhodanine Derivatives as Antimicrobial Agents.
Akhavan M; Foroughifar N; Pasdar H; Bekhradnia A
Comb Chem High Throughput Screen; 2019; 22(10):716-727. PubMed ID: 31775594
[TBL] [Abstract][Full Text] [Related]
31. Synthesis and evaluation of antibacterial activity of 7-alkyloxy-4,5-dihydro-imidazo[1,2-a]quinoline derivatives.
Sun XY; Wu R; Wen X; Guo L; Zhou CP; Li J; Quan ZS; Bao J
Eur J Med Chem; 2013 Feb; 60():451-5. PubMed ID: 23321259
[TBL] [Abstract][Full Text] [Related]
32. Synthesis, Characterization, Anticancer and Antibacterial Activity of Some Novel Pyrano[2,3-d]pyrimidinone Carbonitrile Derivatives.
Aremu OS; Gopaul K; Kadam P; Singh M; Mocktar C; Singh P; Koorbanally NA
Anticancer Agents Med Chem; 2017; 17(5):719-725. PubMed ID: 27528181
[TBL] [Abstract][Full Text] [Related]
33. Design, synthesis and biological evaluation of simplified side chains of the macrolide antibiotic etnangien.
Altendorfer M; Irschik H; Menche D
Bioorg Med Chem Lett; 2012 Sep; 22(17):5731-4. PubMed ID: 22832317
[TBL] [Abstract][Full Text] [Related]
34. Quercetin diacylglycoside analogues showing dual inhibition of DNA gyrase and topoisomerase IV as novel antibacterial agents.
Hossion AM; Zamami Y; Kandahary RK; Tsuchiya T; Ogawa W; Iwado A; Sasaki K
J Med Chem; 2011 Jun; 54(11):3686-703. PubMed ID: 21534606
[TBL] [Abstract][Full Text] [Related]
35. Investigation of antibiotic and antibacterial agent cross-resistance in target bacteria from homes of antibacterial product users and nonusers.
Cole EC; Addison RM; Rubino JR; Leese KE; Dulaney PD; Newell MS; Wilkins J; Gaber DJ; Wineinger T; Criger DA
J Appl Microbiol; 2003; 95(4):664-76. PubMed ID: 12969278
[TBL] [Abstract][Full Text] [Related]
36. Synthesis, Antimicrobial Activity and Molecular Docking of Novel Thiourea Derivatives Tagged with Thiadiazole, Imidazole and Triazine Moieties as Potential DNA Gyrase and Topoisomerase IV Inhibitors.
Hashem HE; Amr AEE; Nossier ES; Elsayed EA; Azmy EM
Molecules; 2020 Jun; 25(12):. PubMed ID: 32549386
[TBL] [Abstract][Full Text] [Related]
37. Implementation of permeation rules leads to a FabI inhibitor with activity against Gram-negative pathogens.
Parker EN; Drown BS; Geddes EJ; Lee HY; Ismail N; Lau GW; Hergenrother PJ
Nat Microbiol; 2020 Jan; 5(1):67-75. PubMed ID: 31740764
[TBL] [Abstract][Full Text] [Related]
38. Activity of and development of resistance to corallopyronin A, an inhibitor of RNA polymerase.
Mariner K; McPhillie M; Trowbridge R; Smith C; O'Neill AJ; Fishwick CW; Chopra I
Antimicrob Agents Chemother; 2011 May; 55(5):2413-6. PubMed ID: 21321139
[TBL] [Abstract][Full Text] [Related]
39. Synthesis and molecular docking studies of novel pyrimidine derivatives as potential antibacterial agents.
Bai XQ; Li CS; Cui MY; Song ZW; Zhou XY; Zhang C; Zhao Y; Zhang TY; Jiang TY
Mol Divers; 2020 Nov; 24(4):1165-1176. PubMed ID: 31792660
[TBL] [Abstract][Full Text] [Related]
40. Isoprenoid Biosynthesis Inhibitors Targeting Bacterial Cell Growth.
Desai J; Wang Y; Wang K; Malwal SR; Oldfield E
ChemMedChem; 2016 Oct; 11(19):2205-2215. PubMed ID: 27571880
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
